lobbying_activities: 3430251

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3430251	0f77a8d8-3960-4a6d-a3b3-416397c4252a	3T	FORBES-TATE	400976792	CSL BEHRING	2025	third_quarter	MED	Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	1	2025-10-10T17:25:11-04:00